These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7648000)
21. The triglyceride connection in atherosclerosis. Geurian K; Pinson JB; Weart CW Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678 [TBL] [Abstract][Full Text] [Related]
22. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids. Westphal S; Orth M; Ambrosch A; Osmundsen K; Luley C Am J Clin Nutr; 2000 Apr; 71(4):914-20. PubMed ID: 10731497 [TBL] [Abstract][Full Text] [Related]
23. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. Peacock RE; Karpe F; Talmud PJ; Hamsten A; Humphries SE Atherosclerosis; 1995 Jul; 116(1):135-45. PubMed ID: 7488328 [TBL] [Abstract][Full Text] [Related]
24. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Mamo JC; Wheeler JR Coron Artery Dis; 1994 Aug; 5(8):695-705. PubMed ID: 8000623 [TBL] [Abstract][Full Text] [Related]
25. [Oxidized dietary lipids may participate in the development of atherosclerosis]. Bałasińska B; Mazur A Postepy Hig Med Dosw (Online); 2004 Mar; 58():176-82. PubMed ID: 15280795 [TBL] [Abstract][Full Text] [Related]
26. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis. Nakajima K; Tanaka A Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553 [TBL] [Abstract][Full Text] [Related]
27. [Cutting-edge research on the metabolism of remnant lipoproteins]. Yamamura T; Ishigami M Rinsho Byori; 2010 Jun; 58(6):613-21. PubMed ID: 20662274 [TBL] [Abstract][Full Text] [Related]
28. Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast. Steiner G Ann Med; 1993 Oct; 25(5):431-5. PubMed ID: 8251140 [TBL] [Abstract][Full Text] [Related]
29. Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats. Proctor SD; Pabla CK; Mamo JC Atherosclerosis; 2000 Apr; 149(2):315-22. PubMed ID: 10729381 [TBL] [Abstract][Full Text] [Related]
30. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis. Nakajima K; Tanaka A Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667 [TBL] [Abstract][Full Text] [Related]
31. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall--evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Proctor SD; Mamo JC Eur J Clin Invest; 1998 Jun; 28(6):497-503. PubMed ID: 9693943 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons. Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451 [TBL] [Abstract][Full Text] [Related]
34. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. Gotto AM Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246 [TBL] [Abstract][Full Text] [Related]
35. Relative atherogenicity of different plasma lipoproteins. Zilversmit DB Adv Exp Med Biol; 1978; 109():45-59. PubMed ID: 215009 [TBL] [Abstract][Full Text] [Related]
36. The atherogenic plasma remnant-like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients. Twickler TB; Dallinga-Thie GM; Zelissen PM; Koppeschaar HP; Erkelens DW Clin Endocrinol (Oxf); 2001 Jul; 55(1):69-75. PubMed ID: 11453954 [TBL] [Abstract][Full Text] [Related]
37. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [TBL] [Abstract][Full Text] [Related]
38. Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall. Öörni K; Lehti S; Sjövall P; Kovanen PT Curr Med Chem; 2019; 26(9):1701-1710. PubMed ID: 29848270 [TBL] [Abstract][Full Text] [Related]
39. Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome. Arca M Atheroscler Suppl; 2015 Feb; 17():12-6. PubMed ID: 25659871 [TBL] [Abstract][Full Text] [Related]
40. Atherogenic lipids and lipoproteins in hemodialysis patients. Cheung AK; Wu LL; Kablitz C; Leypoldt JK Am J Kidney Dis; 1993 Aug; 22(2):271-6. PubMed ID: 8352253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]